Aadi Bioscience

+$0.52 (+1.98%) As of 3:39 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AADI and other ETFs, options, and stocks.

About AADI

Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancers patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes.

CEO
Neil P. Desai, PhD
Employees
12
Headquarters
Los Angeles, California
Founded
—

AADI Key Statistics

Market Cap
84.67M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
64.17K
High Today
$26.96
Low Today
$26.04
Open Price
$26.19
Volume
10.72K
52 Week High
$49.80
52 Week Low
$14.31

AADI Earnings

-$0.40
-$0.19
$0.02
$0.23
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure